Evidence map›Paper›PMID 36779854›Full record

ArticleeLife2023

Csf1 from marrow adipogenic precursors is required for osteoclast formation and hematopoiesis in bone.

Leilei Zhong, Jiawei Lu, Jiankang Fang, Lutian Yao, Wei Yu, Tao Gui, Michael Duffy, Nicholas Holdreith, Catherine A Bautista, Xiaobin Huang and 9 more

Open access · goldFull text read
In one paragraph

Article in eLife, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
6.8field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 44 citations in OpenAlex.

  1. Review
  2. Youthfulness of marrow AdipoqBone research · 2026
    Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Deep imaging of LepRBone research · 2025
    Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 5 institutions in 2 countries.

Leilei ZhongDepartment of Orthopaedic Surgery, Perelman School of Medicine, University of Pennsylvania, Philadelphia, United States.
Jiawei LuDepartment of Orthopaedic Surgery, Perelman School of Medicine, University of Pennsylvania, Philadelphia, United States.
Jiankang FangDepartment of Orthopaedic Surgery, Perelman School of Medicine, University of Pennsylvania, Philadelphia, United States.
Lutian YaoDepartment of Orthopaedic Surgery, Perelman School of Medicine, University of Pennsylvania, Philadelphia, United States.
Wei YuDepartment of Orthopaedic Surgery, Perelman School of Medicine, University of Pennsylvania, Philadelphia, United States.
Tao GuiDepartment of Orthopaedic Surgery, Perelman School of Medicine, University of Pennsylvania, Philadelphia, United States.
Michael DuffyDepartment of Orthopaedic Surgery, Perelman School of Medicine, University of Pennsylvania, Philadelphia, United States.
Nicholas HoldreithDivision of Hematology, Children's Hospital of Philadelphia, Philadelphia, United States.
Catherine A BautistaDepartment of Orthopaedic Surgery, Perelman School of Medicine, University of Pennsylvania, Philadelphia, United States.
Xiaobin HuangDepartment of Oral and Maxillofacial Surgery/Pharmacology, School of Dental Medicine, University of Pennsylvania, Philadelphia, United States.
Shovik BandyopadhyayGraduate Group in Cell and Molecular Biology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, United States.
Kai TanDepartment of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, United States.
Chider ChenDepartment of Oral and Maxillofacial Surgery/Pharmacology, School of Dental Medicine, University of Pennsylvania, Philadelphia, United States.ORCID 0000-0003-2899-1208
Yongwon ChoiDepartment of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, United States.
Jean X JiangDepartment of Biochemistry and Structural Biology, University of Texas Health Science Center at San Antonio, San Antonio, United States.ORCID 0000-0002-2185-5716
Shuying YangDepartment of Basic and Translational Sciences, School of Dental Medicine, University of Pennsylvania, Philadelphia, United States.ORCID 0000-0002-7126-6901
Wei TongDivision of Hematology, Children's Hospital of Philadelphia, Philadelphia, United States.
Nathanial DymentDepartment of Orthopaedic Surgery, Perelman School of Medicine, University of Pennsylvania, Philadelphia, United States.ORCID 0000-0001-8708-112X
Ling QinDepartment of Orthopaedic Surgery, Perelman School of Medicine, University of Pennsylvania, Philadelphia, United States.ORCID 0000-0002-2582-0078
University of Pennsylvania · USChildren's Hospital of Philadelphia · USFirst Affiliated Hospital of Jinan University · CNHuazhong University of Science and Technology · CNThe University of Texas Health Science Center at San Antonio · US

Funding

TRANSGENIC COREP30AG013319 · NIA · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI JAMES FLOYD NELSON · 1995 to 2026
$30.6M
HEMATOLOGY CLINICAL RESEARCH TRAINING PROGRAMT32HL007439 · NHLBI · UNIVERSITY OF PENNSYLVANIA · PI LAWRENCE F BRASS, PETER S KLEIN · 1985 to 2026
$17.1M
Overall: Resource-based Center for Musculoskeletal Disorders Research (Overall Application)P30AR069619 · NIAMS · UNIVERSITY OF PENNSYLVANIA · PI LOUIS J SOSLOWSKY · 2016 to 2026
$9.1M
Regulation of Ribosome Biogenesis in Hematopoietic Stem CellsR01DK127738 · NIDDK · CHILDREN'S HOSP OF PHILADELPHIA · PI TONG, WEI · 2020 to 2024
$3.0M
Novel Regulation of Oncogenic NRAS Signaling in Myeloid MalignanciesR01CA271523 · NCI · CHILDREN'S HOSP OF PHILADELPHIA · PI Wei Tong · 2022 to 2026
$2.7M
Control of bone physiology by a novel type of adipose cellsR01AG069401 · NIA · UNIVERSITY OF PENNSYLVANIA · PI QIN, LING · 2021 to 2025
$2.3M
CSF-1 Gene Expression in Osteoclast BiologyR01AG045040 · NIA · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI JIANG, JEAN X · 2013 to 2017
$1.5M
Defining the Tendon Lineage to Improve Tissue Engineering StrategiesR00AR067283 · NIAMS · UNIVERSITY OF PENNSYLVANIA · PI DYMENT, NATHANIEL A. · 2017 to 2019
$719k
Fat and synovial tissue remodeling in joint osteoarthritisR21AR078650 · NIAMS · UNIVERSITY OF PENNSYLVANIA · PI QIN, LING, SEALE, PATRICK · 2021 to 2021
$393k
NCI NIH HHS R01 CA271523NHLBI NIH HHS T32 HL007439NHLBI NIH HHS T32HL007439NIAMS NIH HHS P30 AR069619NIAMS NIH HHS R00 AR067283NIAMS NIH HHS R00AR067283NIAMS NIH HHS R21 AR078650NIAMS NIH HHS R21AR078650NIA NIH HHS P30 AG013319NIA NIH HHS R01 AG045040NIA NIH HHS R01AG045040NIA NIH HHS R01 AG069401NIA NIH HHS R01AG069401NIDDK NIH HHS R01 DK127738
6 · The paper itself

Abstract

Colony-stimulating factor 1 (Csf1) is an essential growth factor for osteoclast progenitors and an important regulator for bone resorption. It remains elusive which mesenchymal cells synthesize

Indexed as

Bone MarrowOsteoclastsAnimalsBone and BonesHematopoiesisMacrophage Colony-Stimulating FactorMiceMacrophage Colony-Stimulating Factorbonecell biologyCsf1hematopoiesismarrow adipogenic lineage precursorsmedicinemouseosteoclasts

Identifiers

PMID36779854
PMCPMC10005765
OpenAlexW4320490453

What OpenQuestion holds

Textfull text, public
LicenceCC BY
measurements read62
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.